QID 378602

Date Published: 2023-07-04

QID 378602: Splunk Enterprise Persistent Cross-Site Scripting (XSS) Vulnerability (SVD-2023-0605)

A Splunk dashboard view lets a low-privileged user exploit a vulnerability in the Bootstrap web framework (CVE-2019-8331) and build a stored cross-site scripting (XSS) payload.

Affected Versions:
Splunk versions 8.1.0 to 8.1.13
Splunk versions 8.2.0 to 8.2.10
Splunk versions 9.0.0 to 9.0.4

QID Detection Logic(Authenticated)
Linux: Checks for installed vulnerable version of Splunk Enterprise along with the workaround in place or not. from "/etc/splunk.version" file either in "/opt/splunk" directory or using "$SPLUNK_HOME" environment variable.
Windows: Checks for installed vulnerable version of Splunk along with the workaround in place or not. from "/etc/splunk.version" file using registry "HKLM\SYSTEM\CurrentControlSet\Services\Splunkd".

Successful exploit may allow a low-privileged user build a stored cross-site scripting (XSS) payload.

  • CVSS V3 rated as Medium - 5.4 severity.
  • CVSS V2 rated as Medium - 5.5 severity.
    • Solution
    Vendor has released updated versions to fix these vulnerabilities. Please refer SVD-2023-0605 for more details.

    Workaround:
    If users do not log in to Splunk Web on indexers in a distributed environment, disable Splunk Web on those indexers.

    Vendor References

    CVEs related to QID 378602

    CVE-2023-32711 |
    Software Advisories
    Advisory ID Software Component Link
    SVD-2023-0605 URL Logo advisory.splunk.com/advisories/SVD-2023-0605
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].